Workflow
Enfusion(ENFN)
icon
Search documents
Enfusion(ENFN) - 2022 Q3 - Quarterly Report
2022-11-09 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |----------------------------------------------------------------------------|--------------------------------------------------------------------- ...
Enfusion(ENFN) - 2022 Q2 - Earnings Call Transcript
2022-08-13 19:33
Enfusion, Inc. (NYSE:ENFN) Q2 2022 Results Conference Call August 9, 2022 5:00 PM ET Company Participants Ignatius Njoku - Head, IR Thomas Kim - CEO Steve Dorton - CFO Conference Call Participants Matthew Kicker - Stifel Tanaka Mehta - Bank of America James Faucette - Morgan Stanley Faith Brunner - William Blair Operator Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion's Second Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference c ...
Enfusion(ENFN) - 2022 Q2 - Quarterly Report
2022-08-09 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |----------------------------------------------------------------------------|-------------------------------------------------------------------------- ...
Enfusion(ENFN) - 2022 Q1 - Earnings Call Transcript
2022-05-14 03:15
Enfusion, Inc. (NYSE:ENFN) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Ignatius Njoku - Head, IR Thomas Kim - CEO Steve Dorton - CFO Conference Call Participants Dylan Becker - William Blair Matthew Kikkert - Stifel Tanika Mehra - Bank of America Gabriela Borges - Goldman Sachs Chris Donat - Piper Sandler James Faucette - Morgan Stanley Operator Good afternoon. Thank you for attending today's Enfusion First Quarter Fiscal Year 2022 Earnings Call. My name is Tanya and I will ...
Enfusion(ENFN) - 2022 Q1 - Quarterly Report
2022-05-12 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |----------------------------------------------------------------------------|------------------------------------------------------------------------- ...
Enfusion(ENFN) - 2021 Q4 - Annual Report
2022-03-29 16:00
Table of Contents Name Of Each Exchange OnWhichRegistered UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission file number: 001-40949 ENFUSION, INC. (Exact name of registrant as specified in its charter) Delaware ...
Enfusion(ENFN) - 2021 Q4 - Earnings Call Transcript
2022-03-25 03:14
Enfusion, Inc. (NYSE:ENFN) Q4 2021 Results Earnings Conference Call March 24, 2022 5:00 PM ET Company Participants Ignatius Njoku - Head of Investor Relations, Thomas Kim - Chief Executive Officer Steve Dorton - Chief Financial Officer. Conference Call Participants Bhavan Suri - William Blair Parker Lane - Stifel Koji Ikeda - Bank of America Kevin McVeigh - Credit Suisse Gabriela Borges - Goldman Sachs Chris Donat - Piper Sandler Operator … [Abrupt Start] At this time, all lines have been placed on mute to ...
Enfusion(ENFN) - 2021 Q3 - Quarterly Report
2021-12-02 16:00
Table of Contents Title of each class Trading symbol Name of Exchange on which registered Class A common stock, par value $0.001 per share ENFN New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transitio ...